2Ringel I, Horwitz SB. Studies with RP56976 (taxotere) :A semisynthetic analogue of taxol[ J]. J Natl Cancer Inst, 1991,83(4) : 288.
3Ajani JA, Ilson DH, Daugherty K, et al. Activity of Taxol in patient with squamous cell carcinoma and adenocarcinoma of the esophagus[J]. J Natl Cancer Inst, 1994,86 : 1086.
4Vanhoefer U, Caos, Harsttick A. Comparative antitumor efficacy of docetaxel and paclitaxel in nude mice bearing human tumor[J]. Ann Oncol,1997,8(12) :1121.
5Einzig AI, Neuberg D, Remicd SC, et al. Phase Ⅱ trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group(ECOG) results of protocol E1293 [ J ]. Med Oncol, 1996,13 (2) :83-93.
6META-ANALYSIS GROUP IN CANCER. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer[ J ]. Clin Oncol, 1998,16 ( 1 ) :301-308.
7Ilson DH, Ajani J, Bhalla K, et al. Phase Ⅱ trial of pactitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus[J]. J Clin Oncol, 1998, 16(5 ) :1826.
8Wagner AD,Grothe W,Haerting J,et al.Chemotherapy in ad-vanced gastric cancer:a systematic review and meta-analysisbased on aggregate data[ J].J Clin Oncol,2006,24(18):2903-2909.
9Haller DG,Misset JL.Docetaxel in advanced gastric cancer [ J].Anticancer Drugs,2002,13(5):451-460.
10Park KW,Ahn JS,Park YS,et al.Phase II study of docetaxeland cisplatin combination chemotherapy in metastatic gastriccancer [ J].Cancer Chemother Pharmacol,2007,59(1):17.